Clinical trial
Circulating Factors in Nephrotic Syndrome - A Prospective Observational Cohort Study
NCT06315504 is registered in ClinicalTrials.gov with Iain Bressendorff as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Circulating Factors in Nephrotic Syndrome - A Prospective Observational Cohort Study
- Lead sponsor
- Iain Bressendorff
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 1, 2024
- Completion date
- April 1, 2034
- Enrollment
- 104 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
membranous nephropathy, minimal change disease, nephrotic syndrome, primary focal segmental glomerulosclerosis